NCT03480152 2020-06-02
Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
National Institutes of Health Clinical Center (CC)
sigma-tau i.f.r. S.p.A.
Sir Mortimer B. Davis - Jewish General Hospital
M.D. Anderson Cancer Center